Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 16299227)

Published in Clin Cancer Res on November 15, 2005

Authors

Colleen Cutcliffe1, Donna Kersey, Chiang-Ching Huang, Yong Zeng, David Walterhouse, Elizabeth J Perlman, Renal Tumor Committee of the Children's Oncology Group

Author Affiliations

1: Department of Pathology and Laboratory Medicine, Division of Hematology/Oncology, Children's Memorial Hospital, Chicago, Illinois 60614, USA.

Articles citing this

Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. J Clin Invest (2009) 1.67

Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate. Expert Opin Ther Targets (2010) 1.62

HtrA serine proteases as potential therapeutic targets in cancer. Curr Cancer Drug Targets (2009) 1.25

Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study. Neoplasia (2012) 1.19

Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets. Lab Invest (2010) 1.11

Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney. Nat Commun (2015) 1.09

Carboxypeptidase E: elevated expression correlated with tumor growth and metastasis in pheochromocytomas and other cancers. Cell Mol Neurobiol (2010) 1.02

Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidney. Oncotarget (2015) 0.99

Comparative evaluation of set-level techniques in predictive classification of gene expression samples. BMC Bioinformatics (2012) 0.98

DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene MAGEA11. Epigenetics (2013) 0.96

Clear cell sarcoma of the kidney demonstrates an embryonic signature indicative of a primitive nephrogenic origin. Genes Chromosomes Cancer (2014) 0.93

TCF21 hypermethylation in genetically quiescent clear cell sarcoma of the kidney. Oncotarget (2015) 0.91

Clear cell sarcoma of the kidney in children: experience in a developing country. Pediatr Surg Int (2010) 0.89

Genetics of pediatric renal tumors. Pediatr Nephrol (2012) 0.85

Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study. Br J Cancer (2014) 0.84

Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients. PLoS One (2015) 0.82

Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors. J Exp Clin Cancer Res (2010) 0.82

c-KIT overexpression, without gene amplification and mutation, in paediatric renal tumours. J Clin Pathol (2007) 0.82

Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome. Oncotarget (2016) 0.76

Aberrant epigenetic regulation in clear cell sarcoma of the kidney featuring distinct DNA hypermethylation and EZH2 overexpression. Oncotarget (2016) 0.75

N-terminal truncated carboxypeptidase E expression is associated with poor prognosis of lung adenocarcinoma. Oncol Lett (2016) 0.75

MXRA5 is a TGF-β1-regulated human protein with anti-inflammatory and anti-fibrotic properties. J Cell Mol Med (2016) 0.75

Revealing the role of VEGFA in clear cell sarcoma of the kidney by protein-protein interaction network and significant pathway analysis. Oncol Lett (2015) 0.75

Silencing of carboxypeptidase E inhibits cell proliferation, tumorigenicity, and metastasis of osteosarcoma cells. Onco Targets Ther (2016) 0.75

Voltage-gated calcium channels: Novel targets for cancer therapy. Oncol Lett (2017) 0.75

Articles by these authors

Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med (2002) 21.28

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med (2003) 8.48

Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics (2010) 7.78

A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg (2010) 4.75

Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics (2002) 4.56

Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J Biol Chem (2001) 2.56

POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res (2003) 2.45

Calibrating the end-Permian mass extinction. Science (2011) 2.41

Terahertz metamaterials for linear polarization conversion and anomalous refraction. Science (2013) 2.34

Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group. Cancer (2013) 2.32

Sugar-sweetened beverage, sugar intake of individuals, and their blood pressure: international study of macro/micronutrients and blood pressure. Hypertension (2011) 2.29

Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol (2006) 2.15

Facing up to the threat in China. Lancet (2010) 2.03

Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci U S A (2003) 1.86

Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor. Pediatr Blood Cancer (2006) 1.74

Laparoscopy versus open distal gastrectomy for advanced gastric cancer: a systematic review and meta-analysis. Surg Laparosc Endosc Percutan Tech (2013) 1.72

Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol (2004) 1.69

Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res (2002) 1.67

Adenosine-stress dynamic myocardial perfusion imaging with second-generation dual-source CT: comparison with conventional catheter coronary angiography and SPECT nuclear myocardial perfusion imaging. AJR Am J Roentgenol (2012) 1.67

RANTES expression is a predictor of survival in stage I lung adenocarcinoma. Clin Cancer Res (2002) 1.67

Gene therapy for choroideremia: in vitro rescue mediated by recombinant adenovirus. Vision Res (2003) 1.63

Dietary starch intake of individuals and their blood pressure: the International Study of Macronutrients and Micronutrients and Blood Pressure. J Hypertens (2009) 1.61

Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA (2005) 1.59

Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int (2007) 1.56

Light damage induced changes in mouse retinal gene expression. Exp Eye Res (2004) 1.54

Sonic hedgehog activates mesenchymal Gli1 expression during prostate ductal bud formation. Dev Biol (2002) 1.54

Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group. Pediatr Blood Cancer (2014) 1.50

Retinoschisin gene therapy and natural history in the Rs1h-KO mouse: long-term rescue from retinal degeneration. Invest Ophthalmol Vis Sci (2007) 1.47

Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. Cancer Res (2003) 1.46

Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. Blood (2006) 1.46

Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One (2012) 1.45

Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology (2002) 1.44

Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group. Pediatr Blood Cancer (2007) 1.43

Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882. J Clin Oncol (2004) 1.42

A retinal neuronal developmental wave of retinoschisin expression begins in ganglion cells during layer formation. Invest Ophthalmol Vis Sci (2004) 1.40

Effect of statins in preventing contrast-induced nephropathy: an updated meta-analysis. Coron Artery Dis (2014) 1.38

MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. Cancer Lett (2013) 1.38

Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. J Clin Oncol (2004) 1.37

High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor. J Clin Oncol (2005) 1.35

Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod (2007) 1.34

Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. Cancer Res (2007) 1.33

Children's Oncology Group's 2013 blueprint for research: renal tumors. Pediatr Blood Cancer (2012) 1.32

Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a. Clin Cancer Res (2011) 1.30

Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group. J Clin Oncol (2006) 1.30

Management of Wilms' tumour: current practice and future goals. Lancet Oncol (2004) 1.28

N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma. Cancer Res (2006) 1.28

Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5. Ann Surg (2010) 1.28

Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development. Cancer Res (2009) 1.26

Synaptic pathology in retinoschisis knockout (Rs1-/y) mouse retina and modification by rAAV-Rs1 gene delivery. Invest Ophthalmol Vis Sci (2008) 1.24

Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study. Cancer (2005) 1.20

miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase. PLoS One (2011) 1.20

Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis. J Invest Dermatol (2013) 1.19

Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study. Neoplasia (2012) 1.19

Activation of signaling pathways and stress-response genes in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci (2006) 1.18

Retinoschisin is a peripheral membrane protein with affinity for anionic phospholipids and affected by divalent cations. Invest Ophthalmol Vis Sci (2007) 1.18

Depleting Rac1 in mouse rod photoreceptors protects them from photo-oxidative stress without affecting their structure or function. Proc Natl Acad Sci U S A (2009) 1.14

Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg (2003) 1.14

Bilateral Wilms' tumors with progressive or nonresponsive disease. J Pediatr Surg (2006) 1.14

Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease. J Infect Dis (2011) 1.12

Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets. Lab Invest (2010) 1.11

Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol (2003) 1.11

Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. Mol Cell Proteomics (2003) 1.11

Sonic hedgehog-responsive genes in the fetal prostate. J Biol Chem (2008) 1.11

hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors. Am J Pathol (2003) 1.11

RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors. Cancer Genet Cytogenet (2007) 1.10

CITED1 expression in Wilms' tumor and embryonic kidney. Neoplasia (2007) 1.10

Epigenetic differences between Wilms' tumours in white and east-Asian children. Lancet (2004) 1.10

TGFBR1*6A enhances the migration and invasion of MCF-7 breast cancer cells through RhoA activation. Cancer Res (2008) 1.09

Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling. Cancer Res (2002) 1.08

Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol (2002) 1.08

Transcriptional diversity during monocyte to macrophage differentiation. Immunol Lett (2008) 1.06

Single-cell multiplex gene detection and sequencing with microfluidically generated agarose emulsions. Angew Chem Int Ed Engl (2011) 1.06

Renal medullary carcinoma and ABL gene amplification. J Urol (2005) 1.05

Bilateral Wilms' tumor with anaplasia: lessons from the National Wilms' Tumor Study. J Pediatr Surg (2006) 1.05

Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes. Int J Cancer (2009) 1.04

Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor. J Clin Oncol (2013) 1.04

Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology. Lab Chip (2014) 1.03

Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases. J Gastrointest Surg (2010) 1.03

Contribution of resistance-nodulation-division efflux pump operon smeU1-V-W-U2-X to multidrug resistance of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2011) 1.03

Expression profiling and binding properties of fibrinogen-related proteins (FREPs), plasma proteins from the schistosome snail host Biomphalaria glabrata. Innate Immun (2008) 1.03

Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation. Int J Neuropsychopharmacol (2006) 1.02

Allelic variation of serotonin transporter function modulates the brain electrical response for error processing. Neuropsychopharmacology (2004) 1.02

A regulatory polymorphism in interferon-gamma receptor 1 promoter is associated with the susceptibility to chronic hepatitis B virus infection. Immunogenetics (2009) 1.02

Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study. Int J Radiat Oncol Biol Phys (2011) 1.02

Surgical Management for Giant liver Hemangiomas Greater Than 20 cm in Size. Gut Liver (2011) 1.01

Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor. Genes Chromosomes Cancer (2011) 1.01

Anxiety-related traits in mice with modified genes of the serotonergic pathway. Eur J Pharmacol (2003) 1.00

Characterization of immune genes from the schistosome host snail Biomphalaria glabrata that encode peptidoglycan recognition proteins and gram-negative bacteria binding protein. Immunogenetics (2007) 1.00

Primary synovial sarcoma of the kidney diagnosed by molecular detection of SYT-SSX fusion transcripts. J Urol (2002) 1.00

IGF2/H19 imprinting analysis of human germ cell tumors (GCTs) using the methylation-sensitive single-nucleotide primer extension method reflects the origin of GCTs in different stages of primordial germ cell development. Genes Chromosomes Cancer (2005) 1.00

Symbiosis-promoting and deleterious effects of NopT, a novel type 3 effector of Rhizobium sp. strain NGR234. J Bacteriol (2008) 0.99

Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization. Mod Pathol (2006) 0.99

Long-term (15 years) outcome in an infant with metastatic adrenocortical carcinoma. J Clin Endocrinol Metab (2002) 0.98

Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. Neoplasia (2002) 0.98

What is new in rhabdomyosarcoma management in children? Paediatr Drugs (2012) 0.98

Visual presentation as a welcome alternative to textual presentation of gene annotation information. Adv Exp Med Biol (2010) 0.97

Solid pseudopapillary tumor of the pancreas: the surgical procedures. Surg Today (2010) 0.97